Cargando…

miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury

Mitochondrial injury-triggered podocyte apoptosis is a major risk factor for diabetic nephropathy (DN). However, the detailed relationship between mitochondrial homeostasis and podocyte apoptosis remains unclear. The present study aimed to explore the role and functional mechanism of germacrone in D...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yunguang, Feng, Fangfang, He, Wenfang, Sun, Lifang, He, Qiang, Jin, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805940/
https://www.ncbi.nlm.nih.gov/pubmed/34847832
http://dx.doi.org/10.1080/21655979.2021.2012919
_version_ 1784643333851709440
author Wang, Yunguang
Feng, Fangfang
He, Wenfang
Sun, Lifang
He, Qiang
Jin, Juan
author_facet Wang, Yunguang
Feng, Fangfang
He, Wenfang
Sun, Lifang
He, Qiang
Jin, Juan
author_sort Wang, Yunguang
collection PubMed
description Mitochondrial injury-triggered podocyte apoptosis is a major risk factor for diabetic nephropathy (DN). However, the detailed relationship between mitochondrial homeostasis and podocyte apoptosis remains unclear. The present study aimed to explore the role and functional mechanism of germacrone in DN in type I diabetes (type I DN). A mouse model of type I DN was established by injecting streptozocin, and a podocyte injury model was constructed using high glucose (HG) induction. Histopathology was detected by hematoxylin and eosin and periodic acid-Schiff staining. Transmission electron microscopy and flow cytometry were used to evaluate the mitochondrial function. Germacrone simultaneously reduced blood glucose, 24 h proteinuria, and other nephrotic symptoms in a type 1 DN mouse model. Moreover, germacrone protected against mitochondrial damage, limited reactive oxygen species (ROS) accumulation, and restored glutathione peroxidase (GPX) activity and GPX4 protein expression, subsequently preventing podocyte apoptosis. Mechanistically, the increased miR-188-3p expression in type I DN mice was reversed in germacrone-challenged DN mice. HG induced miR-188-3p expression and the miR-188-3p antagonist abolished the HG-mediated increase in ROS. Notably, miR-188-3p was found to have a therapeutic effect against DN by aggravating mitochondrial damage and podocyte apoptosis. Germacrone alleviates DN progression in type I diabetes by limiting podocyte apoptosis, which was partly counteracted by miR-188-3p upregulation. The combination of germacrone and miR-188-3p antagonists is expected to be an effective therapeutic strategy for DN. Abbreviations DN: diabetic nephropathy; Type I DN: DN in Type I diabetes; STZ: streptozocin; ROS: reactive oxygen species; NcRNAs: non-coding RNAs; UTR: untranslated regions; NC: negative control; BUN: blood urea nitrogen; BUA: blood uric acid; Ucr: urine creatinine; Scr: serum creatinine; PAS: Periodic Acid-Schiff; IF: Immunofluorescence; FISH: Fluorescence in situ hybridization; TUG1: taurine upregulated gene 1; GPX: Glutathione Peroxidase; GPX4: glutathione peroxidase 4; EMT: epithelial-mesenchymal transition
format Online
Article
Text
id pubmed-8805940
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88059402022-02-02 miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury Wang, Yunguang Feng, Fangfang He, Wenfang Sun, Lifang He, Qiang Jin, Juan Bioengineered Research Paper Mitochondrial injury-triggered podocyte apoptosis is a major risk factor for diabetic nephropathy (DN). However, the detailed relationship between mitochondrial homeostasis and podocyte apoptosis remains unclear. The present study aimed to explore the role and functional mechanism of germacrone in DN in type I diabetes (type I DN). A mouse model of type I DN was established by injecting streptozocin, and a podocyte injury model was constructed using high glucose (HG) induction. Histopathology was detected by hematoxylin and eosin and periodic acid-Schiff staining. Transmission electron microscopy and flow cytometry were used to evaluate the mitochondrial function. Germacrone simultaneously reduced blood glucose, 24 h proteinuria, and other nephrotic symptoms in a type 1 DN mouse model. Moreover, germacrone protected against mitochondrial damage, limited reactive oxygen species (ROS) accumulation, and restored glutathione peroxidase (GPX) activity and GPX4 protein expression, subsequently preventing podocyte apoptosis. Mechanistically, the increased miR-188-3p expression in type I DN mice was reversed in germacrone-challenged DN mice. HG induced miR-188-3p expression and the miR-188-3p antagonist abolished the HG-mediated increase in ROS. Notably, miR-188-3p was found to have a therapeutic effect against DN by aggravating mitochondrial damage and podocyte apoptosis. Germacrone alleviates DN progression in type I diabetes by limiting podocyte apoptosis, which was partly counteracted by miR-188-3p upregulation. The combination of germacrone and miR-188-3p antagonists is expected to be an effective therapeutic strategy for DN. Abbreviations DN: diabetic nephropathy; Type I DN: DN in Type I diabetes; STZ: streptozocin; ROS: reactive oxygen species; NcRNAs: non-coding RNAs; UTR: untranslated regions; NC: negative control; BUN: blood urea nitrogen; BUA: blood uric acid; Ucr: urine creatinine; Scr: serum creatinine; PAS: Periodic Acid-Schiff; IF: Immunofluorescence; FISH: Fluorescence in situ hybridization; TUG1: taurine upregulated gene 1; GPX: Glutathione Peroxidase; GPX4: glutathione peroxidase 4; EMT: epithelial-mesenchymal transition Taylor & Francis 2022-01-05 /pmc/articles/PMC8805940/ /pubmed/34847832 http://dx.doi.org/10.1080/21655979.2021.2012919 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Wang, Yunguang
Feng, Fangfang
He, Wenfang
Sun, Lifang
He, Qiang
Jin, Juan
miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury
title miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury
title_full miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury
title_fullStr miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury
title_full_unstemmed miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury
title_short miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury
title_sort mir-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type i diabetes through triggering mitochondrial injury
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805940/
https://www.ncbi.nlm.nih.gov/pubmed/34847832
http://dx.doi.org/10.1080/21655979.2021.2012919
work_keys_str_mv AT wangyunguang mir1883pabolishesgermacronemediatedpodocyteprotectioninamousemodelofdiabeticnephropathyintypeidiabetesthroughtriggeringmitochondrialinjury
AT fengfangfang mir1883pabolishesgermacronemediatedpodocyteprotectioninamousemodelofdiabeticnephropathyintypeidiabetesthroughtriggeringmitochondrialinjury
AT hewenfang mir1883pabolishesgermacronemediatedpodocyteprotectioninamousemodelofdiabeticnephropathyintypeidiabetesthroughtriggeringmitochondrialinjury
AT sunlifang mir1883pabolishesgermacronemediatedpodocyteprotectioninamousemodelofdiabeticnephropathyintypeidiabetesthroughtriggeringmitochondrialinjury
AT heqiang mir1883pabolishesgermacronemediatedpodocyteprotectioninamousemodelofdiabeticnephropathyintypeidiabetesthroughtriggeringmitochondrialinjury
AT jinjuan mir1883pabolishesgermacronemediatedpodocyteprotectioninamousemodelofdiabeticnephropathyintypeidiabetesthroughtriggeringmitochondrialinjury